Snowden Capital Advisors LLC Novo Nordisk A S Transaction History

Snowden Capital Advisors LLC

$3.12 Billion
Q4 2024

A detailed history of Snowden Capital Advisors LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Snowden Capital Advisors LLC holds 49,433 shares of NVO stock, worth $4.35 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

49,433

Previous 110,318 55.19%

Holding current value

$4.35 Million

Previous $13.1 Million 67.63%

% of portfolio

0.14%

Previous 0.4%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$85.0 - $120.04 $5.18 Million - $7.31 Million	-60,885 Reduced 55.19%	49,433 $4.25 Million
Q3 2024 Nov 14, 2024	BUY	$119.07 - $145.42 $1.21 Million - $1.48 Million	10,187 Added 10.17%	110,318 $13.1 Million
Q2 2024 Aug 14, 2024	BUY	$122.71 - $146.91 $206,643 - $247,396	1,684 Added 1.71%	100,131 $14.3 Million
Q1 2024 May 15, 2024	BUY	$102.11 - $135.92 $399,556 - $531,854	3,913 Added 4.14%	98,447 $12.6 Million
Q4 2023 Feb 14, 2024	BUY	$87.78 - $105.45 $3.29 Million - $3.95 Million	37,464 Added 65.65%	94,534 $9.78 Million
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $1.69 Million - $3.7 Million	18,557 Added 48.18%	57,070 $5.19 Million
Q2 2023 Aug 14, 2023	BUY	$155.98 - $172.65 $1.84 Million - $2.04 Million	11,816 Added 44.26%	38,513 $6.23 Million
Q1 2023 May 15, 2023	SELL	$132.34 - $159.14 $211,611 - $254,464	-1,599 Reduced 5.65%	26,697 $4.25 Million
Q4 2022 Feb 13, 2023	BUY	$102.55 - $135.33 $140,493 - $185,402	1,370 Added 5.09%	28,296 $3.83 Million
Q3 2022 Nov 09, 2022	SELL	$95.28 - $116.93 $5.11 Million - $6.27 Million	-53,664 Reduced 66.59%	26,926 $2.68 Million
Q2 2022 Aug 12, 2022	BUY	$103.24 - $121.81 $7.03 Million - $8.29 Million	68,064 Added 543.38%	80,590 $8.98 Million
Q1 2022 May 16, 2022	BUY	$93.1 - $112.54 $651,420 - $787,442	6,997 Added 126.55%	12,526 $1.39 Million
Q4 2021 Feb 14, 2022	BUY	$95.88 - $117.08 $530,120 - $647,335	5,529 New	5,529 $619,000
Q3 2021 Feb 05, 2024	SELL	$84.42 - $106.62 $3.87 Million - $4.89 Million	-45,831 Reduced 80.31%	11,239 $1.08 Billion
Q2 2021 Jan 08, 2024	BUY	$67.66 - $84.76 $134,305 - $168,248	1,985 Added 24.39%	10,123 $848 Million
Q1 2021 Jan 08, 2024	BUY	$67.06 - $75.82 $221,633 - $250,585	3,305 Added 68.38%	8,138 $549 Million
Q4 2020 Jan 08, 2024	BUY	$63.89 - $73.8 $308,780 - $356,675	4,833 New	4,833 $338 Million
Q1 2020 Jan 08, 2024	SELL	$49.46 - $64.78 $313,675 - $410,834	-6,342 Closed	0 $0
Q4 2019 Jan 30, 2024	SELL	$49.86 - $58.26 $2.53 Million - $2.96 Million	-50,728 Reduced 88.89%	6,342 $367 Million
Q4 2019 Jan 08, 2024	SELL	$49.86 - $58.26 $17 Million - $19.8 Million	-340,158 Reduced 98.17%	6,342 $367 Million
Q3 2019 Jan 08, 2024	BUY	$47.54 - $53.43 $16.5 Million - $18.5 Million	346,500 New	346,500 $179 Million
Q1 2019 Jan 08, 2024	SELL	$46.36 - $52.63 $341,765 - $387,988	-7,372 Closed	0 $0
Q4 2018 Jan 08, 2024	SELL	$41.54 - $47.25 $23,968 - $27,263	-577 Reduced 7.26%	7,372 $340 Million
Q3 2018 Jan 08, 2024	BUY	$46.76 - $51.24 $67,334 - $73,785	1,440 Added 22.12%	7,949 $375 Million
Q2 2018 Jan 08, 2024	BUY	$44.29 - $50.42 $15,280 - $17,394	345 Added 5.6%	6,509 $300 Million
Q1 2018 Jan 08, 2024	SELL	$48.49 - $58.14 $2.47 Million - $2.96 Million	-50,906 Reduced 89.2%	6,164 $304 Million

Others Institutions Holding NVO

# of Institutions

1,881

Shares Held

336M

Call Options Held

11.9M

Put Options Held

10.6M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $199B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Snowden Capital Advisors LLC with notifications on news.

Account

Snowden Capital Advisors LLC Novo Nordisk A S Transaction History